Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Stevens-Johnson Syndrome

• Evaluation of the Efficacy and Safety of Methylprednisolone Combined With the JAK Inhibitors in the Treatment of Toxic Epidermal Necrolysis
• Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.
• LYell SYndrome MEsenchymal Stromal Cells Treatment
• Severe Bullous Drug Eruption and Filgrastim
• PRF in Management of Chronic Multiple Oral Ulcers
• NATIENS: Optimal Management and Mechanisms of SJS/TEN
• Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study
• G-CSF in the Treatment of Toxic Epidermal Necrolysis
• Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
• Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
• Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
• Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
• Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
• Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
• Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
• Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)